Morales, Noravella B.
HRN: 23-16-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
MEBENDAZOLE 500MG (TAB)
06/28/2023
07/01/2023
PO
500mg
2 Tabs Now Then 1 Tab OF X 3 Doses
Biliary Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes